1. Home
  2. ONC vs EQT Comparison

ONC vs EQT Comparison

Compare ONC & EQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • EQT
  • Stock Information
  • Founded
  • ONC 2010
  • EQT 1925
  • Country
  • ONC Switzerland
  • EQT United States
  • Employees
  • ONC N/A
  • EQT N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • EQT Oil & Gas Production
  • Sector
  • ONC Health Care
  • EQT Energy
  • Exchange
  • ONC Nasdaq
  • EQT Nasdaq
  • Market Cap
  • ONC 31.5B
  • EQT 33.9B
  • IPO Year
  • ONC N/A
  • EQT N/A
  • Fundamental
  • Price
  • ONC $299.01
  • EQT $52.35
  • Analyst Decision
  • ONC Strong Buy
  • EQT Buy
  • Analyst Count
  • ONC 9
  • EQT 19
  • Target Price
  • ONC $332.44
  • EQT $60.84
  • AVG Volume (30 Days)
  • ONC 411.4K
  • EQT 10.1M
  • Earning Date
  • ONC 08-06-2025
  • EQT 07-22-2025
  • Dividend Yield
  • ONC N/A
  • EQT 1.20%
  • EPS Growth
  • ONC N/A
  • EQT 20.64
  • EPS
  • ONC N/A
  • EQT 1.92
  • Revenue
  • ONC $4,175,868,000.00
  • EQT $7,103,623,000.00
  • Revenue This Year
  • ONC $865.19
  • EQT $64.38
  • Revenue Next Year
  • ONC $21.12
  • EQT $23.02
  • P/E Ratio
  • ONC N/A
  • EQT $27.19
  • Revenue Growth
  • ONC 51.16
  • EQT 60.31
  • 52 Week Low
  • ONC $155.75
  • EQT $30.02
  • 52 Week High
  • ONC $308.87
  • EQT $61.02
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • EQT 41.38
  • Support Level
  • ONC N/A
  • EQT $51.07
  • Resistance Level
  • ONC N/A
  • EQT $54.48
  • Average True Range (ATR)
  • ONC 0.00
  • EQT 1.87
  • MACD
  • ONC 0.00
  • EQT -0.31
  • Stochastic Oscillator
  • ONC 0.00
  • EQT 13.80

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About EQT EQT Corporation

EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.

Share on Social Networks: